HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Selectivity of raubasine stereoisomers for alpha 1- and alpha 2-adrenoceptors in the rat.

Abstract
The selectivity of raubasine and its two isomers tetrahydroalstonine (THA) and akuammigine (AKU) for alpha 1- and alpha 2-adrenoceptors has been investigated in pithed normotensive rats. alpha 1-Adrenoceptor blockade was measured by inhibition of the pressor response to (-)-phenylephrine. alpha 2-Adrenoceptor blockade was measured by antagonism of the inhibitory effect of clonidine both on the tachycardia produced by electrical stimulation of the cardiac accelerator nerves and on the pressor response to B-HT 933. Pressor responses to (-)-phenylephrine were reduced in a dose-dependent manner by raubasine but not by THA and AKU. The inhibitory effect of clonidine and the pressor response to B-HT 933 were antagonized in a dose-dependent manner by THA but not by raubasine and AKU. These results indicate that, in pithed rats, AKU is a very weak antagonist at alpha 1- and alpha 2-adrenoceptors, raubasine is a preferential alpha 1-adrenoceptor antagonist, and THA is a selective alpha 2-adrenoceptor antagonist.
AuthorsJ Roquebert
JournalArchives internationales de pharmacodynamie et de therapie (Arch Int Pharmacodyn Ther) Vol. 282 Issue 2 Pg. 252-61 (Aug 1986) ISSN: 0003-9780 [Print] Belgium
PMID3021076 (Publication Type: Journal Article)
Chemical References
  • Azepines
  • Receptors, Adrenergic, alpha
  • Secologanin Tryptamine Alkaloids
  • Yohimbine
  • raubasine
  • azepexole
Topics
  • Animals
  • Azepines (pharmacology)
  • Blood Pressure (drug effects)
  • Decerebrate State
  • Heart (drug effects)
  • Heart Rate (drug effects)
  • In Vitro Techniques
  • Male
  • Models, Biological
  • Rats
  • Rats, Inbred Strains
  • Receptors, Adrenergic, alpha (drug effects)
  • Secologanin Tryptamine Alkaloids
  • Stereoisomerism
  • Yohimbine (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: